Men's Health

Principal Investigator: Dr. Jeffrey Campbell
Co-Investigator: Dr. Blayne Welk
Study Coordinator:  
Mary McKibbon 519.646.6100 ext 65308
Hospital: St. Joseph's Hospital

Prospective evaluation of postoperative pain and opioid use after minor urologic surgery



Principal Investigator:
Dr. Jeffrey Campbell
Study Coordinator: Mary McKibbon 519.646.6100 ext 65308
Hospital:
St. Joseph's Hospital

Feasibility study of cysteine proteases as an alternative treatment for Peyronie’s disease



Principal Investigator: Dr. Jeffrey Campbell

Study Coordinator: Mary McKibbon 519.646.6100 ext 65308
Hospital: St. Joseph's Hospital

Development of an organotypic penile skin-microbiome co-culture model for study of the penile microbiome and its effects on HIV susceptibility


Principal Investigator: Dr. Jeffrey Campbell
Study Coordinator: Mary McKibbon 519.646.6100 ext 65308
Hospital: St. Joseph's Hospital

Safety and effectiveness study of the Zenflow spring system- a minimally invasive treatment for LUTS associated with BPH (BREEZE)


Principal Investigator: Dr. Jeffrey Campbell
Phone: 519.646.6087
In clinic verapamil use for the treatment of Peyronie’s disease


Principal Investigator: Dr. Jeffrey Campbell
Phone:
519.646.6087
Shockwave therapy as a treatment for male lower urinary tract symptoms 


Principal Investigator: Dr. Jeffrey Campbell
Phone:
519.646.6087
Shockwave therapy as a treatment for chronic pelvic pain



Principal Investigator:  Dr. Nicholas Power
Hospital Site:  London Health Sciences Centre - Victoria Hospital

RPLND Seminoma: A Phase II Single-Arm Study of Primary Retroperitoneal Lymph Node Dissection in Patients with Testicular Seminoma with Limited Retroperitoneal Metastases NCT06932458
Study Coordinator: Stephen Mardell: 519.685.8500 x58448 (stephen.mardell@lhsc.on.ca)
Status: Accruing



Coming Soon:

Principal Investigator: Dr. Jeffrey Campbell
Co-Investigator: Dr. Blayne Welk
Study Coordinator:  Mary McKibbon 519.646.6100 ext 65308
Hospital: St. Joseph's Hospital

A multi-center, randomized, blinded, controlled study to evaluate the safety and efficacy of the Urocross Expander system and retrieval sheath (EXPANDER-2)
Prospective evaluation of postoperative pain and opioid use after minor urologic surgery